Prohost Research, established in 1992, includes scientific analysts, clinicians, and
professionals in various specialties which comprise the core disciplines of the
biotechnology industry. We have devised an exceptional, exclusive strategy that evaluates
the research oriented biotechnology firms.
Biotechnology
companies' proprietary technologies are assessed for uniqueness, and their products for
therapeutic value, feasibility, cost-effectiveness and probability of success. The method
takes into consideration market potential, the competition, the capabilities and practices
of the management, as well as other factors that could play important roles in
transforming small start-up companies into full-fledged twenty-first century
pharmaceutical conglomerates.
|
Click for subscription info |
